Becton Dickinson Debt to Equity Ratio 2010-2024 | BDX

Current and historical debt to equity ratio values for Becton Dickinson (BDX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Becton Dickinson debt/equity for the three months ending June 30, 2024 was 0.70.
Becton Dickinson Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $29.71B $25.87B 1.15
2024-03-31 $28.51B $25.65B 1.11
2023-12-31 $26.94B $25.33B 1.06
2023-09-30 $26.98B $25.80B 1.05
2023-06-30 $27.08B $25.94B 1.04
2023-03-31 $28.71B $25.69B 1.12
2022-12-31 $27.66B $25.47B 1.09
2022-09-30 $27.65B $25.28B 1.09
2022-06-30 $27.71B $25.49B 1.09
2022-03-31 $30.26B $24.53B 1.23
2021-12-31 $29.20B $24.16B 1.21
2021-09-30 $30.19B $23.68B 1.28
2021-06-30 $30.20B $24.14B 1.25
2021-03-31 $30.09B $24.83B 1.21
2020-12-31 $30.09B $24.66B 1.22
2020-09-30 $30.25B $23.77B 1.27
2020-06-30 $29.94B $24.02B 1.25
2020-03-31 $32.57B $20.95B 1.55
2019-12-31 $30.75B $21.20B 1.45
2019-09-30 $30.68B $21.08B 1.46
2019-06-30 $30.74B $21.50B 1.43
2019-03-31 $31.29B $21.31B 1.47
2018-12-31 $31.53B $21.40B 1.47
2018-09-30 $32.91B $20.99B 1.57
2018-06-30 $32.62B $21.36B 1.53
2018-03-31 $33.42B $21.15B 1.58
2017-12-31 $34.12B $21.25B 1.61
2017-09-30 $24.79B $12.95B 1.91
2017-06-30 $24.58B $12.59B 1.95
2017-03-31 $16.16B $7.96B 2.03
2016-12-31 $16.74B $7.58B 2.21
2016-09-30 $17.95B $7.63B 2.35
2016-06-30 $17.98B $8.03B 2.24
2016-03-31 $18.57B $7.67B 2.42
2015-12-31 $18.82B $7.22B 2.61
2015-09-30 $19.31B $7.16B 2.70
2015-06-30 $19.83B $7.25B 2.73
2015-03-31 $21.13B $7.16B 2.95
2014-12-31 $13.44B $5.07B 2.65
2014-09-30 $7.39B $5.05B 1.46
2014-06-30 $7.00B $5.38B 1.30
2014-03-31 $6.94B $5.32B 1.31
2013-12-31 $6.96B $5.08B 1.37
2013-09-30 $7.11B $5.04B 1.41
2013-06-30 $6.87B $4.72B 1.46
2013-03-31 $7.04B $4.59B 1.53
2012-12-31 $7.16B $4.47B 1.60
2012-09-30 $7.23B $4.14B 1.75
2012-06-30 $6.79B $4.24B 1.60
2012-03-31 $6.72B $4.48B 1.50
2011-12-31 $6.69B $4.73B 1.41
2011-09-30 $5.60B $4.83B 1.16
2011-06-30 $5.32B $5.30B 1.01
2011-03-31 $5.25B $5.10B 1.03
2010-12-31 $5.19B $4.88B 1.07
2010-09-30 $4.22B $5.44B 0.78
2010-06-30 $3.88B $5.15B 0.75
2010-03-31 $3.79B $5.15B 0.74
2009-12-31 $3.83B $5.26B 0.73
2009-09-30 $4.16B $5.14B 0.81
2009-06-30 $3.64B $5.21B 0.70
2009-03-31 $2.77B $4.80B 0.58
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.388B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95